1	REDWOOD	redwood	NNP	p2=NN	2	nn	_
2	CITY	city	NNP	_	0	root	_
3	,	,	,	_	2	punct	_
4	Calif	calif	NNP	_	2	appos	_
5	.	.	.	_	4	punct	_

1	,	,	,	_	13	punct	_
2	May	may	NNP	_	13	nn	_
3	19	0	CD	_	2	num	_
4	,	,	,	_	13	punct	_
5	2014	0	CD	_	11	num	_
6	/	/	SYM	p2=,	11	punct	_
7	CNW	cnw	NNP	_	10	nn	_
8	/	/	SYM	p2=,	10	hmod	_
9	-	-	HYPH	p2=:	10	hyph	_
10	Coherus	coherus	NNP	_	11	nn	_
11	BioSciences	biosciences	NNP	p2=NNPS	13	nn	_
12	,	,	,	_	13	punct	_
13	Inc	inc	NNP	_	0	root	_
14	.	.	.	_	13	punct	_

1	(	(	-LRB-	_	3	punct	_
2	"	"	``	_	3	punct	_
3	Coherus	coherus	NNP	p2=FW	16	nsubj	16:A0=PAG
4	"	"	''	_	3	punct	_
5	)	)	-RRB-	_	3	punct	_
6	,	,	,	_	3	punct	_
7	a	a	DT	_	11	det	_
8	leading	lead	VBG	p2=NN|pb=lead.01	9	amod	_
9	biologics	biologics	NNS	p2=NN	11	nn	8:A0=PAG
10	platform	platform	NN	p2=VB	11	nn	_
11	company	company	NN	_	3	appos	12:A1=PPT
12	focused	focus	VBD	pb=focus.01	11	partmod	_
13	on	on	IN	_	12	prep	12:A2=PPT
14	biosimilars	biosimilars	NNS	_	13	pobj	_
15	,	,	,	_	3	punct	_
16	announced	announce	VBD	pb=announce.01	0	root	_
17	today	today	NN	_	16	npadvmod	16:AM-TMP
18	the	the	DT	p2=IN	19	det	_
19	closing	closing	NN	_	16	dobj	16:A1=PPT
20	of	of	IN	_	19	prep	_
21	a	a	DT	_	26	det	_
22	Series	series	NNP	_	24	nn	_
23	C	c	NNP	_	24	nn	_
24	Preferred	preferred	NNP	_	26	nn	_
25	investment	investment	NN	_	26	nn	_
26	round	round	NN	p2=RB	20	pobj	27:A0=PAG
27	raising	raise	VBG	pb=raise.02	26	partmod	_
28	$	$	$	_	30	quantmod	_
29	55	0	CD	_	30	number	_
30	million	#crd#	CD	_	27	dobj	27:A1=PPT
31	.	.	.	_	16	punct	_

1	New	new	NNP	p2=JJ	3	nn	_
2	investors	investor	NNS	p2=NNPS	3	nn	_
3	KKR	kkr	NNP	_	0	root	_
4	&	&	CC	_	3	cc	_
5	Co.	co.	NNP	_	6	nn	_
6	L.P.	l.p.	NNP	_	3	conj	_
7	(	(	-LRB-	_	9	punct	_
8	"	"	``	_	9	punct	_
9	KKR	kkr	NNP	_	25	nsubj	25:A0=PAG
10	"	"	''	_	9	punct	_
11	)	)	-RRB-	_	9	punct	_
12	,	,	,	_	9	punct	_
13	Venrock	venrock	NNP	_	9	conj	_
14	,	,	,	_	13	punct	_
15	RA	ra	NNP	_	17	nn	_
16	Capital	capital	NNP	_	17	nn	_
17	Management	management	NNP	_	13	conj	_
18	,	,	,	_	17	punct	_
19	Rock	rock	NNP	_	20	nn	_
20	Springs	springs	NNP	_	21	nn	_
21	Capital	capital	NNP	_	17	conj	_
22	and	and	CC	_	21	cc	_
23	Fidelity	fidelity	NNP	_	24	nn	_
24	Biosciences	biosciences	NNP	p2=NNS	21	conj	_
25	joined	join	VBD	pb=join.01	6	rcmod	_
26	existing	exist	VBG	pb=exist.01	27	amod	_
27	investors	investor	NNS	_	25	dobj	25:A1=PPT;26:A1=PAG
28	Sofinnova	sofinnova	NNP	_	29	nn	_
29	Ventures	ventures	NNP	p2=NNPS	27	appos	_
30	,	,	,	_	29	punct	_
31	Lilly	lilly	NNP	_	32	nn	_
32	Ventures	venture	NNPS	p2=NNP	29	conj	_
33	and	and	CC	_	32	cc	_
34	Vivo	vivo	NNP	_	35	nn	_
35	Capital	capital	NNP	_	32	conj	_
36	in	in	IN	_	35	prep	_
37	the	the	DT	_	38	det	_
38	transaction	transaction	NN	_	36	pobj	_
39	.	.	.	_	25	punct	_

1	"	"	``	_	3	punct	_
2	We	we	PRP	_	3	nsubj	7:A0=PAG;3:A1=PPT
3	are	be	VBP	pb=be.01	24	ccomp	24:A1=PPT
4	very	very	RB	_	5	advmod	_
5	pleased	pleased	JJ	_	3	acomp	3:A2=PRD
6	to	to	TO	_	7	aux	_
7	have	have	VB	pb=have.03	5	xcomp	_
8	the	the	DT	_	9	det	_
9	confidence	confidence	NN	_	7	dobj	7:A1=PPT
10	and	and	CC	_	9	cc	_
11	financial	financial	JJ	_	12	amod	_
12	support	support	NN	_	9	conj	_
13	of	of	IN	_	12	prep	_
14	such	such	PDT	_	17	predet	_
15	an	an	DT	_	17	det	_
16	extraordinary	extraordinary	JJ	_	17	amod	_
17	group	group	NN	_	13	pobj	_
18	of	of	IN	_	17	prep	_
19	health	health	NN	_	20	nn	_
20	care	care	NN	_	21	nn	_
21	investors	investor	NNS	_	18	pobj	_
22	,	,	,	_	24	punct	_
23	"	"	''	_	24	punct	_
24	said	say	VBD	pb=say.01	0	root	_
25	Denny	denny	NNP	_	26	nn	_
26	Lanfear	lanfear	NNP	_	24	nsubj	24:A0
27	,	,	,	_	26	punct	_
28	President	president	NNP	_	26	appos	_
29	and	and	CC	_	28	cc	_
30	CEO	ceo	NNP	p2=NN	28	conj	_
31	of	of	IN	_	28	prep	_
32	Coherus	coherus	NNP	_	31	pobj	_
33	.	.	.	_	24	punct	_

1	"	"	``	p2=''	11	punct	_
2	Since	since	IN	_	11	prep	11:AM-TMP
3	its	its	PRP$	_	4	poss	_
4	founding	founding	NN	p2=CD	2	pobj	_
5	four	#crd#	CD	_	6	num	_
6	years	year	NNS	_	7	npadvmod	_
7	ago	ago	RB	_	4	advmod	_
8	,	,	,	_	11	punct	_
9	Coherus	coherus	NNP	_	11	nsubj	11:A0
10	has	have	VBZ	_	11	aux	_
11	made	make	VBN	pb=make.LV	0	root	_
12	excellent	excellent	JJ	_	13	amod	_
13	progress	progress	NN	_	11	dobj	11:AM-PRR
14	on	on	IN	_	13	prep	_
15	its	its	PRP$	_	16	poss	_
16	goals	goal	NNS	_	14	pobj	_
17	of	of	IN	_	16	prep	_
18	moving	move	VBG	pb=move.01	17	pcomp	_
19	biosimilar	biosimilar	JJ	p2=NN	20	amod	_
20	biologics	biologics	NNS	_	18	dobj	18:A1=PPT
21	into	into	IN	_	18	prep	18:A2=GOL
22	Phase	phase	NNP	p2=NN	21	pobj	_
23	3	0	CD	_	22	num	_
24	trials	trial	NNS	_	21	pobj	_
25	and	and	CC	_	21	cc	_
26	onto	onto	IN	_	21	conj	_
27	the	the	DT	_	28	det	_
28	market	market	NN	_	26	pobj	_
29	.	.	.	_	11	punct	_

1	The	the	DT	_	3	det	_
2	capital	capital	NN	p2=JJ	3	nn	_
3	resources	resource	NNS	_	9	nsubj	9:A0=PAG;4:A1
4	provided	provided	VBN	pb=provide.01	3	partmod	_
5	by	by	IN	_	4	agent	4:A0
6	our	our	PRP$	_	7	poss	_
7	investors	investor	NNS	_	5	pobj	_
8	will	will	MD	_	9	aux	9:AM-MOD
9	allow	allow	VB	pb=allow.01	0	root	_
10	us	us	PRP	_	12	nsubj	12:A0=PAG;17:A0=PAG;22:A0=PAG
11	to	to	TO	_	12	aux	_
12	prosecute	prosecute	VB	pb=prosecute.01	9	ccomp	9:A1=PPT
13	our	our	PRP$	_	15	poss	_
14	development	development	NN	_	15	nn	_
15	plans	plan	NNS	_	12	dobj	12:A1=PPT
16	,	,	,	_	12	punct	_
17	optimize	optimize	VB	p2=VBP|pb=optimize.01	12	conj	_
18	our	our	PRP$	_	20	poss	_
19	partnering	partner	VBG	p2=NN|pb=partner.01	20	amod	_
20	strategies	strategy	NNS	_	17	dobj	17:A1=PPT;19:A1=COM
21	and	and	CC	_	17	cc	_
22	deliver	deliver	VB	pb=deliver.01	17	conj	_
23	essential	essential	JJ	_	24	amod	_
24	therapeutics	therapeutic	NNS	p2=NN	22	dobj	22:A1=PPT
25	to	to	IN	_	22	prep	22:A2=GOL
26	patients	patient	NNS	_	25	pobj	_
27	faster	fast	RBR	p2=JJR	22	advmod	22:AM-MNR
28	.	.	.	_	9	punct	_
29	"	"	''	_	9	punct	_

1	As	as	IN	_	20	prep	20:AM-ADV
2	part	part	NN	_	1	pobj	_
3	of	of	IN	_	2	prep	_
4	the	the	DT	_	5	det	_
5	transaction	transaction	NN	_	3	pobj	_
6	,	,	,	_	20	punct	_
7	Ali	ali	NNP	_	8	nn	_
8	Satvat	satvat	NNP	_	20	nsubj	20:A0=PAG
9	,	,	,	_	8	punct	_
10	Director	director	NNP	_	8	appos	_
11	on	on	IN	_	10	prep	_
12	KKR	kkr	NNP	_	17	poss	_
13	's	's	POS	_	12	possessive	_
14	health	health	NN	_	15	nn	_
15	care	care	NN	_	17	nn	_
16	investing	invest	VBG	p2=NN	17	nn	_
17	team	team	NN	_	11	pobj	_
18	,	,	,	_	8	punct	_
19	will	will	MD	_	20	aux	20:AM-MOD
20	join	join	VB	pb=join.01	0	root	_
21	the	the	DT	_	22	det	_
22	Board	board	NNP	_	20	dobj	20:A1=PPT
23	of	of	IN	_	22	prep	_
24	Directors	director	NNPS	p2=NNS	23	pobj	_
25	of	of	IN	_	22	prep	_
26	Coherus	coherus	NNP	p2=NNPS	25	pobj	_
27	.	.	.	_	20	punct	_

1	"	"	``	_	23	punct	_
2	We	we	PRP	_	3	nsubj	6:A0;3:A1=PPT
3	are	be	VBP	pb=be.01	23	ccomp	23:A1=PPT
4	excited	excited	JJ	_	3	acomp	3:A2=PRD
5	to	to	TO	_	6	aux	_
6	support	support	VB	pb=support.01	4	xcomp	_
7	Denny	denny	NNP	_	6	dobj	6:A1
8	and	and	CC	_	7	cc	_
9	his	his	PRP$	_	11	poss	_
10	experienced	experienced	JJ	p2=VBN	11	amod	_
11	team	team	NN	_	7	conj	_
12	on	on	IN	_	11	prep	_
13	their	their	PRP$	_	15	poss	_
14	growth	growth	NN	_	15	nn	_
15	initiatives	initiative	NNS	_	12	pobj	_
16	to	to	TO	_	17	aux	_
17	transform	transform	VB	pb=transform.01	15	infmod	_
18	the	the	DT	_	20	det	_
19	biologics	biologics	NNS	p2=NN	20	nn	_
20	market	market	NN	_	17	dobj	17:A1=PPT
21	,	,	,	_	23	punct	_
22	"	"	''	_	23	punct	_
23	said	say	VBD	pb=say.01	0	root	_
24	Mr.	mr.	NNP	_	25	nn	_
25	Satvat	satvat	NNP	_	23	nsubj	23:A0
26	.	.	.	_	23	punct	_

1	"	"	``	_	3	punct	_
2	We	we	PRP	_	3	nsubj	3:A0=PAG
3	believe	believe	VBP	pb=believe.01	0	root	_
4	that	that	IN	_	8	complm	_
5	the	the	DT	_	7	det	_
6	Coherus	coherus	NNP	p2=JJ	7	nn	_
7	platform	platform	NN	_	8	nsubj	13:A0=PAG;8:A1=PPT
8	is	be	VBZ	pb=be.01	3	ccomp	3:A1=PPT
9	well	well	RB	_	11	hmod	_
10	-	-	HYPH	_	11	hyph	_
11	positioned	position	VBN	_	8	acomp	8:A2=PRD
12	to	to	TO	_	13	aux	_
13	succeed	succeed	VB	pb=succeed.01	11	xcomp	_
14	given	give	VBN	_	13	prep	13:A1=PPT
15	its	its	PRP$	_	17	poss	_
16	product	product	NN	_	17	nn	_
17	pipeline	pipeline	NN	_	14	pobj	_
18	and	and	CC	_	17	cc	_
19	strong	strong	JJ	p2=RB	23	amod	_
20	scientific	scientific	JJ	_	23	amod	_
21	and	and	CC	_	20	cc	_
22	technical	technical	JJ	_	20	conj	_
23	capabilities	capability	NNS	_	17	conj	_
24	.	.	.	_	3	punct	_
25	"	"	''	_	3	punct	_

1	Since	since	IN	_	7	prep	7:AM-TMP
2	its	its	PRP$	_	3	poss	_
3	inception	inception	NN	_	1	pobj	_
4	,	,	,	_	7	punct	_
5	Coherus	coherus	NNP	_	7	nsubj	7:A0=PAG
6	has	have	VBZ	_	7	aux	_
7	raised	raise	VBN	pb=raise.02	0	root	_
8	over	over	IN	p2=RP	7	prep	7:AM-LOC
9	$	$	$	_	11	quantmod	_
10	220	0	CD	_	11	number	_
11	million	#crd#	CD	_	8	pobj	_
12	from	from	IN	_	11	prep	_
13	equity	equity	NN	_	17	nn	_
14	and	and	CC	_	13	cc	_
15	non-dilutive	non-dilutive	JJ	_	13	conj	_
16	licensing	licensing	NN	_	17	nn	_
17	fees	fee	NNS	_	12	pobj	_
18	and	and	CC	_	17	cc	_
19	milestones	milestone	NNS	_	17	conj	_
20	.	.	.	_	7	punct	_

1	About	about	RB	p2=IN	3	advmod	_
2	Coherus	coherus	NNP	_	3	nn	_
3	BioSciences	biosciences	NNP	p2=NNPS	0	root	_
4	,	,	,	_	3	punct	_
5	Inc	inc	NNP	_	3	appos	_
6	.	.	.	_	3	punct	_

1	Coherus	coherus	NNP	p2=NN	2	nsubj	2:A1=PPT
2	is	be	VBZ	pb=be.01	0	root	_
3	a	a	DT	_	7	det	_
4	leading	lead	VBG	p2=NN|pb=lead.01	5	amod	_
5	biologics	biologics	NNS	p2=NN	7	nn	4:A0=PAG
6	platform	platform	NN	p2=VB	7	nn	_
7	company	company	NN	_	2	attr	8:A0=PPT;2:A2=PRD
8	focused	focus	VBD	pb=focus.01	7	partmod	_
9	on	on	IN	_	8	prep	8:A2=PPT
10	delivering	deliver	VBG	pb=deliver.01	9	pcomp	_
11	high	high	JJ	_	13	hmod	_
12	-	-	HYPH	_	13	hyph	_
13	quality	quality	NN	_	15	nn	_
14	biosimilar	biosimilar	NN	p2=JJ	15	nn	_
15	therapeutics	therapeutic	NNS	p2=IN	10	dobj	18:A0=PAG;10:A1=PPT
16	that	that	WDT	_	18	nsubj	18:R-A0
17	will	will	MD	_	18	aux	18:AM-MOD
18	expand	expand	VB	pb=expand.01	15	rcmod	_
19	patient	patient	JJ	_	20	amod	_
20	access	access	NN	_	18	dobj	18:A1=PPT
21	to	to	IN	_	20	prep	_
22	life	life	NN	_	24	hmod	_
23	-	-	HYPH	_	24	hyph	_
24	changing	change	VBG	_	25	amod	_
25	medications	medication	NNS	_	21	pobj	_
26	worldwide	worldwide	RB	_	18	advmod	_
27	.	.	.	_	2	punct	_

1	Headquartered	headquartered	JJ	p2=VBN	28	advcl	28:AM-PRD
2	in	in	IN	_	1	prep	_
3	the	the	DT	_	7	det	_
4	San	san	NNP	_	5	nn	_
5	Francisco	francisco	NNP	_	6	nn	_
6	Bay	bay	NNP	_	7	nn	_
7	Area	area	NNP	_	2	pobj	_
8	and	and	CC	_	1	cc	_
9	founded	found	VBN	pb=found.01	1	conj	_
10	by	by	IN	_	9	agent	9:A0=PAG
11	a	a	DT	_	12	det	_
12	group	group	NN	_	10	pobj	_
13	of	of	IN	_	12	prep	_
14	biotech	biotech	JJ	p2=NN	15	amod	_
15	pioneers	pioneer	NNS	_	13	pobj	18:A0=PAG
16	who	who	WP	_	18	nsubj	18:R-A0
17	helped	help	VBD	_	18	aux	_
18	build	build	VB	p2=VBP|pb=build.01	15	rcmod	_
19	America	america	NNP	_	24	poss	_
20	's	's	POS	_	19	possessive	_
21	first	#ord#	JJ	_	22	amod	_
22	generation	generation	NN	_	23	nn	_
23	biotherapeutics	biotherapeutics	NNS	p2=NN	24	nn	_
24	industry	industry	NN	_	18	dobj	18:A1=PRD
25	,	,	,	_	28	punct	_
26	Coherus	coherus	NNP	_	28	nsubj	28:A0=PAG
27	has	have	VBZ	_	28	aux	_
28	developed	develop	VBN	pb=develop.02	0	root	_
29	a	a	DT	_	32	det	_
30	collaborative	collaborative	JJ	p2=NN	32	amod	_
31	business	business	NN	_	32	nn	_
32	model	model	NN	_	28	dobj	28:A1=PRD
33	that	that	WDT	p2=IN	34	nsubj	_
34	leverages	leverage	VBZ	_	32	rcmod	_
35	a	a	DT	_	37	det	_
36	strategic	strategic	JJ	_	37	amod	_
37	consortium	consortium	NN	_	34	dobj	_
38	of	of	IN	_	37	prep	_
39	service	service	NN	_	40	nn	_
40	providers	provider	NNS	_	38	pobj	41:A1=PPT
41	aligned	align	VBN	pb=align.01	40	partmod	_
42	through	through	IN	_	41	prep	41:A2
43	ownership	ownership	NN	_	42	pobj	_
44	and	and	CC	_	43	cc	_
45	shared	shared	JJ	p2=VBD	46	amod	_
46	incentives	incentive	NNS	_	43	conj	_
47	.	.	.	_	28	punct	_

1	Coherus	coherus	NNP	p2=NN	5	poss	_
2	'	'	POS	p2=``	1	possessive	_
3	global	global	JJ	_	5	amod	_
4	commercialization	commercialization	NN	_	5	nn	_
5	partnerships	partnership	NNS	_	6	nsubj	6:A2=GOL
6	include	include	VBP	pb=include.01	0	root	_
7	top	top	JJ	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	tier	tier	NN	_	11	nn	_
10	biopharma	biopharma	NN	p2=IN	11	nn	_
11	companies	company	NNS	_	6	dobj	6:A1=PPT
12	in	in	IN	_	11	prep	_
13	Europe	europe	NNP	_	12	pobj	_
14	,	,	,	_	13	punct	_
15	Asia	asia	NNP	_	13	conj	_
16	,	,	,	_	15	punct	_
17	and	and	CC	_	15	cc	_
18	Latin	latin	NNP	_	19	nn	_
19	America	america	NNP	_	15	conj	_
20	.	.	.	_	6	punct	_

1	Biosimilars	biosimilars	NNS	p2=NNPS	3	nsubjpass	14:A0=PAG;3:A2=VSP
2	are	be	VBP	_	3	auxpass	_
3	intended	intend	VBN	pb=intend.01	0	root	_
4	for	for	IN	_	3	prep	3:A1=PPT
5	use	use	NN	_	4	pobj	_
6	in	in	IN	_	3	prep	_
7	place	place	NN	_	6	pobj	_
8	of	of	IN	_	7	prep	_
9	existing	exist	VBG	p2=NN|pb=exist.01	12	amod	_
10	,	,	,	_	11	punct	_
11	branded	brand	VBD	p2=VBN|pb=brand.01	12	amod	_
12	biologics	biologics	NNS	_	8	pobj	9:A1=PAG;11:A1
13	to	to	TO	_	14	aux	_
14	treat	treat	VB	pb=treat.01	3	xcomp	_
15	a	a	DT	_	16	det	_
16	range	range	NN	_	14	dobj	14:A1=PPT
17	of	of	IN	_	16	prep	_
18	chronic	chronic	JJ	_	24	amod	_
19	and	and	CC	_	18	cc	_
20	often	often	RB	_	23	advmod	_
21	life	life	NN	_	23	hmod	_
22	-	-	HYPH	_	23	hyph	_
23	threatening	threaten	VBG	_	18	conj	_
24	diseases	disease	NNS	_	17	pobj	_
25	,	,	,	_	14	punct	_
26	with	with	IN	_	14	prep	_
27	the	the	DT	_	28	det	_
28	potential	potential	NN	p2=JJ	26	pobj	_
29	to	to	TO	_	30	aux	_
30	reduce	reduce	VB	pb=reduce.01	14	advcl	_
31	costs	cost	NNS	_	30	dobj	30:A1=PPT
32	and	and	CC	_	30	cc	_
33	expand	expand	VB	pb=expand.01	30	conj	_
34	patient	patient	JJ	p2=NN	35	amod	_
35	access	access	NN	_	33	dobj	33:A1=PPT
36	.	.	.	_	3	punct	_

1	For	for	IN	_	6	prep	6:AM-PRP
2	additional	additional	JJ	_	3	amod	_
3	information	information	NN	_	1	pobj	_
4	,	,	,	_	6	punct	_
5	please	please	UH	p2=VB	6	intj	6:AM-DIS
6	visit	visit	VB	pb=visit.01	0	root	_
7	www.coherus.com	#url#	ADD	_	6	dobj	6:A1=COM
8	.	.	.	_	6	punct	_

